Moreover, it has been shown that in AD there is an up-regulation of d18:1 species of sphingolipids, but recently it has been shown that AD is associated with distinct changes of plasma Cer, such as upregulation of Cer d18:1/16:0 [93]. Here, CBLN1 is linked to Alzheimer disease.